Back
Zoetis Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
47
ZTS
Zoetis
Last Price:
167.02
Seasonality Move:
8.06%
Sell
33
ALNY
Alnylam Pharmaceuticals
Last Price:
152.43
Seasonality Move:
18.94%
Sell
47
Zoetis (ZTS)
is a Sell
Is Zoetis a Buy, Sell or Hold?
- The current Zoetis [ZTS] share price is $167.07. The Score for ZTS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- ZTS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $152.33. The Score for ALNY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $152.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
ZTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.55 | Sell |
| Relative Strength Index (14 RSI): | 58.89 | Buy |
| Chaikin Money Flow: | -2826429 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (151.2 - 165.52) | Buy |
| Bollinger Bands (100): | (165.33 - 197.17) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.77 | Sell |
| Relative Strength Index (14 RSI): | 57.15 | Buy |
| Chaikin Money Flow: | -327925 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (144.95 - 152.75) | Buy |
| Bollinger Bands (100): | (146.97 - 182.91) | Sell |
ZTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 159.3 | Buy |
| 20-day SMA: | 156.63 | Buy |
| 50-day SMA: | 169.44 | Sell |
| 200-day SMA: | 179.66 | Sell |
| 8-day EMA: | 160.58 | Buy |
| 20-day EMA: | 159.51 | Buy |
| 50-day EMA: | 166.79 | Buy |
| 200-day EMA: | 175.8 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 146.83 | Buy |
| 20-day SMA: | 148.05 | Buy |
| 50-day SMA: | 149.82 | Buy |
| 200-day SMA: | 171.39 | Sell |
| 8-day EMA: | 148.3 | Buy |
| 20-day EMA: | 148.13 | Buy |
| 50-day EMA: | 152.17 | Buy |
| 200-day EMA: | 169.04 | Sell |
Zoetis Earnings Growth & ZTS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.15 per share, an increase this year of $0.37 per share, and an increase next year of $0.63 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.38 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.23 per share, and an increase next year of $2.43 per share.
Zoetis Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||